SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-008685
Filing Date
2020-03-04
Accepted
2020-03-04 16:12:42
Documents
13
Period of Report
2020-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 EARNINGS RELEASE - Q4/FY 2019 asmb-8k_20200304.htm   iXBRL 8-K 38819
2 EX-99.1 asmb-ex991_17.htm EX-99.1 314204
  Complete submission text file 0001564590-20-008685.txt   494285

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA asmb-20200304.xsd EX-101.SCH 5980
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE asmb-20200304_lab.xml EX-101.LAB 18731
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asmb-20200304_pre.xml EX-101.PRE 11182
7 EXTRACTED XBRL INSTANCE DOCUMENT asmb-8k_20200304_htm.xml XML 3444
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 20687268
SIC: 2834 Pharmaceutical Preparations